《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 4期

2型糖尿病患者血清Fractalkine与代谢指标相关性的分析

来自:中国糖尿病杂志  编辑:黄莉吉 谢绍锋 赵越 刘敬顺 余江毅|点击数:|2014-04-25

  ·糖尿病与肥胖、脂代谢异常·

  【摘要】 目的 探讨炎症因子Fractalkine(FKN)在T2DM患者不同BMI组中的水平变化及与代谢指标的相关性。 方法 纳入139例T2DM患者,根据BMI分为体重正常组(50例)、超重组(44例)及肥胖组(45例),对相关指标进行统计分析。收集研究对象一般临床资料,测定相关生化指标水平;采用ELISA法检测血清FKN水平。 结果 (1) 3组间血糖、HbA1c比较差异无统计学意义。与正常体重组比较,超重组及肥胖组FKN水平高,而HDL-C水平降低(P均<0.05)。肥胖组BP高于正常体重组,肥胖组血清FKN、ALT、TG水平高于超重组(P均<0.01)。(2)血清FKN水平与BMI(r=0.57,P<0.01)、WC(r=0.40, P<0.01)、TG(r=0.21,P<0.05)呈正相关;多元逐步回归分析结果表明,血清FKN与BMI独立相关(β=0.32, P<0.01,R2=0.40)。 结论 超重和肥胖是T2DM患者FKN水平升高的独立危险因素。

  【关键词】 Fractalkine(FKN);糖尿病,2型;体重指数(BMI);肥胖症

Relationship of serum fractalkine with metabolic index in patients with type 2 diabetes HUANG Li-ji, XIE Shao-feng,ZHAO Yue,et al. Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210029,China

Corresponding author: XIE Shao-feng ,E-mail:xiesf3562@sina.com

  【Abstract】 Objective To investigate the serum fractalkine (FKN) levels in type 2 diabetes patients with different body mass index (BMI) and to analyze the association of serum FKN with metabolic indexes. Methods A total of 139 T2DM patients were enrolled.The basic characteristics and blood chemistries were determined. Serum FKN was measured by enzyme-linked immunosorbent assay (ELISA).According to the levels of BMI,all patients were divided into normal weight group (n=50),over-weight group (n=44) and obese group (n=45). Results Over-weight and obese group had higher FKN and lower high density lipoprotein cholesterol (HDL-C) as compared with normal weight group. Fasting blood glucose and HbA1c showed no significantly difference among three groups. Blood pressures were higher in obese group than in normal weight group(P<0.05). Serum FKN, alanine aminotransferase and triglyceride were significantly higher in obese group than in overweight group(P<0.05). Spearman analysis showed that serum FKN positively correlated with BMI (r=0.57, P<0.01), waist circumference (r=0.07, P=0.39) and with serum triglyceride (r=0.21, P=0.01). Stepwise linear regression analysis showed that BMI was the independent correlated factor for serum fractalkine concentration. Conclusion Overweight and obesity are the risk factors of fractalkine in type 2 diabetic patients.

  【Key words】 Fractalkine(FKN);Diabetes mellitus, type 2;Body mass index (BMI);Obesity

上一篇:广东省2型糖尿病超重及肥胖患者心血管危险因素的现况与控制现状的调查 下一篇:血管生成素2与内质网应激相关基因在肥胖患者内脏脂肪组织中表达及相关关系的研究